Personas / Equipo Humano

Marta Pardo Gallego

Buscador de publicaciones

Publicaciones

  • Casado-Ortega A, Vila R, Butjosa A, del Cacho N, Serra C, Marina Esteban Sanjusto, Diago M, Muñoz D, Pardo M and Usall J.

    Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis

    PSYCHIATRY RESEARCH . 302: 114040-114040. Nº de citas: 5

    [doi:10.1016/j.psychres.2021.114040]

  • Pardo M, Matalí JL, Sivoli J, Vila R, Butjosa A, Dolz M, Sánchez Fernández B, Barajas A, del Cacho N, Baños I, Ochoa S and Usall J.

    Early onset psychosis and cannabis use: Prevalence, clinical presentation and influence of daily use.

    Asian Journal of Psychiatry . 62: 102714-102714. Nº de citas: 11

    [doi:10.1016/j.ajp.2021.102714]

  • Tor J, Dolz M, Sintes A, de la Serna E, Puig O, Muñoz D, Pardo M, Rodríguez-Pascual M, Sugranyes G, Sánchez-Gistau V and Baeza I.

    Neuropsychological profile of children and adolescents with psychosis risk syndrome: the CAPRIS study.

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY . 29(9): 1311-1324. Nº de citas: 11

    [doi:10.1007/s00787-019-01459-6]

  • Mas S, Gassó P, Rodríguez N, Bibiana Cabrera Llorca, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Usall J, Saiz-Ruiz J, Contreras F, Parellada E, Bernardo M and PEPs group.

    Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.

    ACTA PSYCHIATRICA SCANDINAVICA . 141(6): 541-552. Nº de citas: 5

    [doi:10.1111/acps.13131]

  • Sancho-Balsells A, Brito V, Fernández B, Pardo M, Straccia M, Ginés S, Alberch J, Hernández I, Arranz B, Canals JM and Giralt A.

    Lack of Helios During Neural Development Induces Adult Schizophrenia-Like Behaviors Associated With Aberrant Levels of the TRIF-Recruiter Protein WDFY1

    FRONTIERS IN CELLULAR NEUROSCIENCE . 14: 93-93. Nº de citas: 6

    [doi:10.3389/fncel.2020.00093]

  • Dolz M, Tor J, De la Serna E, Pardo M, Muñoz D, Rodríguez-Pascual M, Puig O, Sugranyes G, Usall J, Sánchez-Gistau V and Baeza I.

    Characterization of children and adolescents with psychosis risk syndrome: The Children and Adolescents Psychosis Risk Syndrome (CAPRIS) study.

    EARLY INTERVENTION IN PSYCHIATRY . 13(5): 1062-1072. Nº de citas: 16

    [doi:10.1111/eip.12728]

  • del Cacho N, Butjosa A, Vila R, Cuadras-Palleja D, Kaplan M, Rubio E, Pardo M, Muñoz D, Cuevas-Esteban J, GERARDO SAENZ DE NAVARRETE RIBERA, PROFEP group and Usall J.

    Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences

    PSYCHIATRY RESEARCH . 276: 218-222. Nº de citas: 14

    [doi:10.1016/j.psychres.2019.03.027]

  • Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.

    Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.

    EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Nº de citas: 12

    [doi:10.1111/eip.12498]

  • Tor J, Dolz M, Sintes A, Muñoz D, Pardo M, de la Serna E, Puig O, Sugranyes G and Baeza I.

    Clinical high risk for psychosis in children and adolescents: a systematic review.

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY . 27(6): 683-700. Nº de citas: 46

    [doi:10.1007/s00787-017-1046-3]

  • Matalí JL, Simons J, Pardo M, Lleras M, Pérez A and Andión O.

    Spanish version validation of the Marihuana Motives Measure in a drug-consuming adolescent sample.

    Adicciones . 30(4): 282-291. Nº de citas: 5

    [doi:10.20882/adicciones.947]